dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 23, 2026

Elon Musk's Terafab is here: What it is, and why it's important for Tesla and SpaceX

View original at finance.yahoo.com
Elon Musk's Terafab is here: What it is, and why it's important for Tesla and SpaceX Over the weekend in Austin, Texas, Tesla (TSLA) and SpaceX (SPAX.PVT) CEO Elon Musk unveiled what might be his grandest overarching vision for where he sees his companies headed…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Giga Texas alone is expected to have capacity for 10 million humanoid robots per year, which would require 20 million chips — approximately six times Tesla's current chip demand for its entire auto business

    60% confidence
  • Chipmakers like TSMC and Samsung aren't making chips fast enough for his companies' AI and robotics needs

    60% confidence
  • Goal is to produce more than a terawatt — 1 trillion watts — of AI computing power per year, with most of that capacity ultimately destined for space

    60% confidence
  • Current AI compute output is roughly 20 gigawatts per year and the rest of the world's output is about 2% of what his companies need

    60% confidence
  • Chipmakers' expansion rate is much less than what Musk's companies would like

    60% confidence
  • We either build the Terafab or we don't have the chips, and we need the chips, so we build the Terafab

    60% confidence
  • Terafab is the most epic chip-building exercise in history by far

    60% confidence

Data points we hold from this source

Elon Musk · ai compute output worldwide20 gigawatts_per_year
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Elon Musk's Terafab is here: What it is, and why it's important for Tesla and SpaceX: Source | Via News | fr.via.news